On Friday, Shares of Bristol-Myers Squibb Company (NYSE:BMY), lost -6.58% to $64.60.
Bristol-Myers Squibb Company, declared results from CheckMate -017, a Phase III, open-label, randomized study evaluating Opdivo (n=135) as compared to docetaxel (n=137) in formerly treated patients with advanced squamous non-small cell lung cancer. At one year, Opdivo demonstrated an overall survival rate of 42% as compared to 24% for docetaxel, with a median overall survival of 9.2 months as compared to 6 months, respectively. In the trial, Opdivo reduced the risk of death by 41%, based upon a hazard ratio of 0.59 (95% CI, 0.44-0.79; P = 0.00025). The safety profile of Opdivo in CheckMate -017 was consistent with preceding studies and favorable as compared to docetaxel. Findings from CheckMate -017 were published recently in The New England Journal of Medicine and presented during an oral abstract session at the 51st Annual Meeting of the American Society of Clinical Oncology (Abstract #8009).
Opdivo demonstrated a consistent statistically noteworthy superiority over docetaxel across all secondary endpoints counting overall response rate and progression-free survival. Results showed that at one year, Opdivo improved progression-free survival (21%) as compared to docetaxel (6.4%). Median progression-free survival was 3.5 months for Opdivo and 2.8 months for docetaxel, with a hazard ratio of 0.62 (95% CI, 0.47-0.81; P = 0.0004). Opdivo also produced a significantly higher confirmed objective response rate (20%) as compared to docetaxel (8.8%) (95% CI; P=0.0083). Responses for Opdivo were ongoing and the median duration of response was not reached (range 2.9 to 21+ months) with at least 11 months of follow-up; the median duration of response for docetaxel was 8.4 months (range 1.4+ to 15+ months).
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Shares of UnitedHealth Group Incorporated (NYSE:UNH), inclined 0.49% to $120.21, during its last trading session.
More than 200 youth take partd in the first UnitedHealthcare IRONKIDS® Raleigh Fun Run recently. UnitedHealthcare mascot Dr. Health E. Hound kicked-off the fun run, joined by Anita Bachmann of UnitedHealthcare, and County Commissioners Caroline Sullivan and Sig Hutchinson.
Local athletes, ages 3-15, had the opportunity to run on the same course as the LexisNexis IRONMAN® 70.3® Raleigh presented by PNC, which takes place tomorrow. IRONMAN® pro-athletes Melanie McQuaid and Matty Reed were also on hand with Dr. Health E. Hound to assist warm up the kids, and place medals on them as they crossed the finish line.
This is the fourth year UnitedHealthcare is supporting IRONKIDS as part of the company’s commitment to assist stem the rising tide of childhood obesity through healthy lifestyles. The UnitedHealthcare IRONKIDS 2015 Series features nine one-mile fun-runs and a dip-and-dash.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services.
At the end of Friday’s trade, Shares of Whiting Petroleum Corp. (NYSE:WLL), gained 1.95% to $32.99, as some energy and related stocks got a jolt from the afternoon rally in oil prices.
Crude oil (WTI) was up by 4.40% to $60.22 per barrel and Brent crude gained by 4.59% to $65.45 per barrel, according to the CNBC.com index.
Whiting Petroleum Corporation, an independent oil and gas company, acquires, explores, develops, and produces crude oil, natural gas liquids, and natural gas in the Rocky Mountains and Permian Basin regions of the United States. It sells oil and gas to end users, marketers, and other purchasers.
Finally, Texas Instruments Inc. (NASDAQ:TXN), ended its last trade with 0.02% gain, and closed at $55.92.
Twenty-three top students from across the U.S. joined an elite group of scholars when they were named as recipients of the 2015 Jerry R. Junkins Memorial National Merit Scholarships® at a luncheon recently at the Dallas Arboretum.
The scholarships, named in honor of TI’s late chairman, president and CEO Jerry Junkins, are awarded to sons or daughters of active, stepped down or deceased TI employees who are National Merit Scholarship Program finalists. Since its inception in 1996, TI’s Junkins Merit Scholarship program has awarded 344 scholarships, amounting to more than $1.2 million.
The 20 Texas students honored for their academic achievements this year are Katrina Chen of Allen, homeschooled; Serena Chen of Plano, Plano Senior High School; Minyoung Chung of McKinney, Heritage High School; Bethany Colbert of Carrollton, Hebron High School; Gerald Hu of Plano, Texas Academy of Math and Science; Florence Kam of Richardson, Trinity Christian Academy; Ashley Lee of Dallas, Greenhill School; Ashwin Leo of Carrollton, Texas Academy of Math and Science; I-Chun Lin of Plano, Plano Senior High School; Ian Little of Plano, Plano East Senior High School; Amy Liu of Dallas, Highland Park High School; Adelaide Luhman of Flower Mound, Edward S. Marcus High School; Remya Menon of Dallas, Greenhill School; Rishiprotim (Rik) Nag of Missouri City, Dulles High School; Aditya Nelakonda of Plano, Plano Senior High School; Amy Ong of Plano, Plano West Senior High School; Wellington Lawton Owen of Fort Worth, Robert L. Paschal High School; Thatcher Townson of Celina, homeschooled; Joshua Ying of Plano, Plano Senior High School; and Victoria Zhou of Plano, Plano West Senior High School.
Honorees from other communities comprise Caroline Ho of San Carlos, CA, Sacred Heart Preparatory School; Ye-Rim Park of San Ramon, CA, California High School; and Mingyi Wu of East Greenwich, RI, East Greenwich High School.
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
